Established Ray Bioscience Consulting Ltd. providing advice to Biotech and venture capital companies on the development of new medicines for autoimmune and inflammatory diseases.Research director, project manager and team leader with 21 years of experience and record of achievement in preclinical research and early clinical development at GlaxoSmithKline.Extensive knowledge of small molecule drug discovery, from target validation through lead optimization to candidate selection.Expertise in translational biology including assay development for the measurement of drug pharmacodynamics and identification of disease biomarkers. Supported advancement of 3 drug candidates through Phase I/II clinical trials.Team leader and experienced molecular cell biologist specializing in the development of model systems for target discovery, validation and investigation of drug pharmacology. Manager of multiple academic collaborations and strategic alliances supporting internal drug discovery efforts.Specialties: Management of preclinical and early clinical drug discovery.The development of new medicines for rheumatoid arthritis and chronic respiratory diseases.Cytokines and protein kinases as therapeutic targets in cancer and inflammation.Macrophage regulation and cell biology.